JP2022516957A5 - - Google Patents
Info
- Publication number
- JP2022516957A5 JP2022516957A5 JP2021539682A JP2021539682A JP2022516957A5 JP 2022516957 A5 JP2022516957 A5 JP 2022516957A5 JP 2021539682 A JP2021539682 A JP 2021539682A JP 2021539682 A JP2021539682 A JP 2021539682A JP 2022516957 A5 JP2022516957 A5 JP 2022516957A5
- Authority
- JP
- Japan
- Prior art keywords
- days
- seq
- per month
- headache
- overuse headache
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024195562A JP2025032102A (ja) | 2019-01-08 | 2024-11-08 | 抗ｃｇｒｐ又は抗ｃｇｒｐ－ｒ抗体を用いた薬物乱用頭痛の治療 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962789828P | 2019-01-08 | 2019-01-08 | |
| US62/789,828 | 2019-01-08 | ||
| US201962840967P | 2019-04-30 | 2019-04-30 | |
| US62/840,967 | 2019-04-30 | ||
| US201962841585P | 2019-05-01 | 2019-05-01 | |
| US62/841,585 | 2019-05-01 | ||
| US201962872983P | 2019-07-11 | 2019-07-11 | |
| US62/872,983 | 2019-07-11 | ||
| PCT/US2020/012790 WO2020146535A1 (en) | 2019-01-08 | 2020-01-08 | Treatment of medication overuse headache using anti-cgrp or anti-cgrp-r antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024195562A Division JP2025032102A (ja) | 2019-01-08 | 2024-11-08 | 抗ｃｇｒｐ又は抗ｃｇｒｐ－ｒ抗体を用いた薬物乱用頭痛の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022516957A JP2022516957A (ja) | 2022-03-03 |
| JP2022516957A5 true JP2022516957A5 (cg-RX-API-DMAC10.html) | 2022-12-13 |
Family
ID=71404208
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539682A Withdrawn JP2022516957A (ja) | 2019-01-08 | 2020-01-08 | 抗ｃｇｒｐ又は抗ｃｇｒｐ－ｒ抗体を用いた薬物乱用頭痛の治療 |
| JP2024195562A Pending JP2025032102A (ja) | 2019-01-08 | 2024-11-08 | 抗ｃｇｒｐ又は抗ｃｇｒｐ－ｒ抗体を用いた薬物乱用頭痛の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024195562A Pending JP2025032102A (ja) | 2019-01-08 | 2024-11-08 | 抗ｃｇｒｐ又は抗ｃｇｒｐ－ｒ抗体を用いた薬物乱用頭痛の治療 |
Country Status (24)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3495392T (pt) | 2011-05-20 | 2021-09-22 | H Lundbeck As | Composições anti-cgrp e a sua utilização |
| CN108014334B (zh) | 2011-05-20 | 2021-11-30 | H.伦德贝克公司 | 抗cgrp抗体和抗体片段用于在有需要的受试者中预防或抑制畏光或厌光的用途 |
| EA033109B1 (ru) | 2011-05-20 | 2019-08-30 | Олдербайо Холдингз Ллк | Способы ингибирования, профилактики или лечения диареи и/или поддержания соответствующих уровней электролитов и жидкости в толстой кишке субъекта, подвергающегося связанному с диареей состоянию, с помощью антитела против cgrp или фрагмента антитела против cgrp |
| US20170114122A1 (en) | 2015-10-23 | 2017-04-27 | Alderbio Holdings Llc | Regulation of glucose metabolism using anti-cgrp antibodies |
| CR20210373A (es) | 2019-01-08 | 2021-08-19 | H Lundbeck As | Tratamiento agudo y tratamiento rápido de la cefalea usando anticuerpos anti-cgrp |
| GEAP202515803A (en) | 2019-05-02 | 2025-06-10 | H Lundbeck As | Treatment of headache using anti-cgrp antibodies |
| KR20210124867A (ko) | 2020-04-06 | 2021-10-15 | 하. 룬드벡 아크티에셀스카브 | 항-cgrp 항체를 사용하는 편두통 관련 성가심 증상 (mbs) 의 치료 |
| CN117813325A (zh) * | 2021-08-27 | 2024-04-02 | H.隆德贝克有限公司 | 使用抗cgrp抗体治疗丛集性头痛 |
| US20260125454A1 (en) * | 2022-08-11 | 2026-05-07 | Shanghai Junshi Biosciences Co., Ltd. | Anti-cgrp antibody and use |
| CN118476508A (zh) * | 2024-06-27 | 2024-08-13 | 中国人民解放军总医院第一医学中心 | 一种基于疾病发生特点的药物过度使用性头痛动物模型的构建方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1644004A4 (en) * | 2003-06-20 | 2010-10-06 | Ronald Aung-Din | LOCAL THERAPY FOR THE TREATMENT OF MIGRAINS, MUSCLE CLARIFICATIONS, MUSCLE SPASMS, SPASTICITY AND RELATED CONDITIONS |
| PT3495392T (pt) * | 2011-05-20 | 2021-09-22 | H Lundbeck As | Composições anti-cgrp e a sua utilização |
| CN108014334B (zh) * | 2011-05-20 | 2021-11-30 | H.伦德贝克公司 | 抗cgrp抗体和抗体片段用于在有需要的受试者中预防或抑制畏光或厌光的用途 |
| CN103585449B (zh) * | 2013-10-23 | 2016-06-22 | 高丽丽 | 用于治疗偏头痛的中药组合物 |
| CA2983030A1 (en) * | 2015-04-16 | 2016-10-20 | Alder Biopharmaceuticals, Inc. | Use of anti-pacap antibodies and antigen binding fragments thereof for treatment, prevention, or inhibition of photophobia |
| US11596699B2 (en) * | 2016-04-29 | 2023-03-07 | CureVac SE | RNA encoding an antibody |
| SMT202600087T1 (it) * | 2016-09-23 | 2026-03-09 | Teva Pharmaceuticals Int Gmbh | Trattamento dell’emicrania refrattaria |
| CR20210373A (es) * | 2019-01-08 | 2021-08-19 | H Lundbeck As | Tratamiento agudo y tratamiento rápido de la cefalea usando anticuerpos anti-cgrp |
-
2020
- 2020-01-08 SG SG11202106878XA patent/SG11202106878XA/en unknown
- 2020-01-08 KR KR1020217023581A patent/KR20210114002A/ko not_active Ceased
- 2020-01-08 US US16/736,937 patent/US20200216525A1/en not_active Abandoned
- 2020-01-08 PE PE2021001141A patent/PE20211708A1/es unknown
- 2020-01-08 JP JP2021539682A patent/JP2022516957A/ja not_active Withdrawn
- 2020-01-08 TW TW109100630A patent/TW202030205A/zh unknown
- 2020-01-08 CA CA3123292A patent/CA3123292A1/en active Pending
- 2020-01-08 AU AU2020207299A patent/AU2020207299A1/en active Pending
- 2020-01-08 WO PCT/US2020/012790 patent/WO2020146535A1/en not_active Ceased
- 2020-01-08 BR BR112020018044-0A patent/BR112020018044A2/pt unknown
- 2020-01-08 MA MA054709A patent/MA54709A/fr unknown
- 2020-01-08 PH PH1/2021/551494A patent/PH12021551494A1/en unknown
- 2020-01-08 UA UAA202104194A patent/UA129265C2/uk unknown
- 2020-01-08 GE GEAP202515689A patent/GEAP202515689A/en unknown
- 2020-01-08 GE GEAP202015689A patent/GEP20257804B/en unknown
- 2020-01-08 JO JOP/2021/0166A patent/JOP20210166A1/ar unknown
- 2020-01-08 CN CN202411285298.5A patent/CN119303074A/zh active Pending
- 2020-01-08 EP EP20738512.1A patent/EP3908607A4/en active Pending
- 2020-01-08 CN CN202080007409.XA patent/CN113272324A/zh active Pending
- 2020-01-08 MX MX2021008268A patent/MX2021008268A/es unknown
-
2021
- 2021-06-30 CO CONC2021/0008665A patent/CO2021008665A2/es unknown
- 2021-07-07 IL IL284677A patent/IL284677A/en unknown
- 2021-07-07 DO DO2021000145A patent/DOP2021000145A/es unknown
- 2021-07-07 CL CL2021001813A patent/CL2021001813A1/es unknown
- 2021-07-07 NI NI202100063A patent/NI202100063A/es unknown
- 2021-07-14 EC ECSENADI202152193A patent/ECSP21052193A/es unknown
-
2023
- 2023-11-16 US US18/511,241 patent/US20240343784A1/en active Pending
-
2024
- 2024-11-08 JP JP2024195562A patent/JP2025032102A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022516956A5 (cg-RX-API-DMAC10.html) | ||
| Blondell et al. | Pharmacologic therapy for acute pain | |
| JP5835865B2 (ja) | ロキソプロフェン含有医薬組成物 | |
| JP2002538221A (ja) | 抗てんかん作用を有する化合物を包含する鎮痛組成物およびその使用方法 | |
| CA2555688A1 (en) | Methods of treating osteoarthritis with anti-il-6 or anti-il6 receptor antibodies | |
| JP5897804B2 (ja) | ロキソプロフェン含有の医薬組成物 | |
| US20040209850A1 (en) | Methods of treating pain and compositions for use therefor | |
| Herrero et al. | Antinociception and the new COX inhibitors: research approaches and clinical perspectives | |
| EP3956025A1 (en) | Cgrp antagonists for the treatment of medication overuse headache, post-traumatic headache, post-concussion syndrome and vertigo | |
| TW201420133A (zh) | 針對嚴重頭痛之普拉克索的經皮遞送 | |
| JP7862619B2 (ja) | メロキシカムおよびリザトリプタンを含有する組み合わせの使用 | |
| JPH10505087A (ja) | 非麻薬性鎮痛剤および無痛エンハンサーを含有する疼痛緩和組成物 | |
| CN101115467A (zh) | 止痛剂组合物 | |
| TW202019484A (zh) | 調節對鴉片、鴉片類或鴉片止痛劑之耐受性及治療急性及慢性疼痛之方法及組合 | |
| US8598221B2 (en) | Synergistic combination of analgesic compounds | |
| Gershell et al. | Making gains in pain. | |
| Narbone et al. | Acute drug treatment of migraine attack | |
| Jang et al. | Attenuation of morphine tolerance and withdrawal syndrome by coadministration of nalbuphine | |
| JP2011246433A (ja) | ロキソプロフェン含有医薬組成物 | |
| Reisner-Keller | Pharmacotherapeutics in the management of orofacial pain | |
| US20090270400A1 (en) | Painkilling association comprising a dihydroimidazopyrazine derivative | |
| RU2021133433A (ru) | Лечение головной боли с использованием антител к cgrp | |
| Jansen | Pharmacologic Treatment | |
| WO2025221509A1 (en) | Pharmaceutical compositions comprising meloxicam | |
| JP6027916B2 (ja) | ロキソプロフェン含有医薬組成物 |